Last reviewed · How we verify

Hyaluronic acid (HA) — Competitive Intelligence Brief

Hyaluronic acid (HA) (Hyaluronic acid (HA)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Viscosupplement / Biological polymer. Area: Orthopedics / Rheumatology.

marketed Viscosupplement / Biological polymer Orthopedics / Rheumatology Small molecule Live · refreshed every 30 min

Target snapshot

Hyaluronic acid (HA) (Hyaluronic acid (HA)) — Chinese University of Hong Kong. Hyaluronic acid is a naturally occurring polysaccharide that acts as a biological lubricant and structural component, reducing friction and providing viscoelastic support in joints and tissues.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Hyaluronic acid (HA) TARGET Hyaluronic acid (HA) Chinese University of Hong Kong marketed Viscosupplement / Biological polymer

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Viscosupplement / Biological polymer class)

  1. Chinese University of Hong Kong · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Hyaluronic acid (HA) — Competitive Intelligence Brief. https://druglandscape.com/ci/hyaluronic-acid-ha. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: